Revanesse® Lips™+ 2 Syringes

• PHYSICIAN BACKED. 100% of treating Physicians rated the Revanesse® Lips™+ patients as improved, much improved, or very much improved at 6 months vs. 76.4% for those treated with the comparator.
• PATIENT BACKED. 96.3% of Revanesse® Lips™+ patients rated themselves as improved, much improved, or very much improved at 6 months vs. 83.6% who were treated with the comparator.
• MINIMAL DOWNTIME. There were no unexpected product-related side effects with a Revanesse® Lips™+ treatment. 
• LESS PAIN. Fewer patients reported pain with their Revanesse® Lips™+ treatment.
• LESS PRODUCT REQUIRED. On average Revanesse® Lips™+ required less volume to achieve optimal treatment outcomes.
• MINIMAL SWELLING. 98.1% of patients treated with Revanesse® Lips™+ reported having minimal or no swelling after their first treatment.

What is Revanesse® Lips™+?

Revanesse® Lips™+ is an FDA-approved hyaluronic acid dermal filler that can be used for submucosal implantation for lip augmentation in patients 22 years of age or older.

Are there any reasons (contraindications) I should not receive a Revanesse® Versa™+ or Revanesse® Lips™+ injection?

You should not be treated if you:

• are pregnant or breastfeeding, as the safety of these products for use during pregnancy, or in women who are breastfeeding, has not been studied
• have a history of hypertrophic scarring or keloid formation
• have evidence of scars at the intended treatment sites
• have acne and/or other inflammatory diseases of the skin, such as rosacea, seborrheic dermatitis, and psoriasis,
• have allergic history including severe allergic reactions (anaphylaxis), heightened immune responses to common allergens, especially inhaled allergens and food allergens (atopy), allergy to hyaluronic acid products, allergy to lidocaine, Streptococcal proteins or have plans to undergo administration of graded doses of allergens (desensitization therapy) during treatment with Revanesse®.
• have an acute or chronic skin disease, such as seborrheic dermatitis or rosacea, in or near the injection sites, or any infection or unhealed wound of the face
• are under concomitant anticoagulant therapy, antiplatelet therapy, or have a history of bleeding disorders, clotting disorders such as hemophilia, or connective tissue disorders such as systemic lupus erythematosus
• If you are under the age of 22 you should not be treated with a Revanesse® dermal filler.
• It’s not recommended to use Revanesse® dermal fillers in conjunction with a laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with Over-the-counter (OTC) wrinkle products or prescription wrinkle treatments within 4 weeks before treatment, as there is a possible risk of inflammation or infection at the treatment site.

What are the risks?

The most common reported side effects are bleeding, bruising, swelling, and pain.
Other risks that are less likely, but may occur, include Acne-like skin eruptions, skin sensitivity (rash, itching, tenderness), skin infection, damage to nerves or blood vessels, skin lumpiness, scarring, skin necrosis, hyperpigmentation, reactivation of herpes infection (blisters or skin sores).